Delivery Order SPE2DB22D2007-SPE2DB26FH6PQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,983.80 to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5) with a 5-sensor configuration. The contract was competitively awarded without set-aside designation and carries a completion date of June 10, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $8,655.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5, 5-pack configuration) on August 25, 2025, with completion scheduled for August 26, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $14,233.56 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of OmniPod 5 continuous glucose monitoring pods (Generation 5) for 5-day use. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award draws...
- The Defense Logistics Agency awarded a $33,921.62 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5, 5-unit packs) on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The products will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $2,486.25 delivery order contract to AmerisourceBergen Drug Corp for OmniPod 5 DexG7G6 Pods (Generation 5) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,047.70 to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5) on June 2, 2025, with completion expected by June 3, 2025. This firm fixed-price delivery order, which involves no set-aside designation, will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a $6,381.97 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 DEXG7G6 Pods (Gen 5) 5S, a diabetes management device. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order was placed on July 18, 2025, with an ultimate completion date of July...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $48,000 to AmerisourceBergen Drug Corp for OmniPod 5 DexG7G6 Pods (Generation 5) with a 5-unit configuration. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 25, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. As a child delivery order, this award derives from AmerisourceBergen's substantial...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,603.61 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 continuous glucose monitoring system pods (Generation 5), with performance in Conshohocken, Pennsylvania. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as the prime contractor under this...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 pods (Generation 5) in the 5-pack configuration, valued at $4,407.61. This is a firm fixed-price delivery order with no set-aside designation, issued on June 18, 2025, with an ultimate completion date of June 20, 2025. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, will serve as the place of performance. This delivery order is issued under...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB26FH6PQDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,454.28 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5) on October 29, 2025, with completion by October 30, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies critical medical commodities to federal healthcare systems supporting military personnel and veterans through the DLA's Medical Supply Chain. As the prime vendor under the SPE2DX contract, the company delivers a comprehensive range of pharmaceutical products and medical devices across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This specific delivery order for glucose monitoring pods supports the DLA's healthcare procurement mission and demonstrates the company's ongoing role in supplying advanced diabetes management technology to federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/29/25 |